3,4-Isopropylidenedioxyamphetamine

IDA
Clinical data
Other names	IDA; Isopropylidenedioxyamphetamine
Drug class	Monoamine releasing agent; Entactogen; Serotonergic psychedelic; Hallucinogen
ATC code	None;
Identifiers
	IUPAC name 1-(2,2-dimethyl-1,3-benzodioxol-5-yl)propan-2-amine;
PubChem CID	130544;
ChemSpider	115480;
ChEMBL	ChEMBL3250329;
Chemical and physical data
Formula	C12H17NO2
Molar mass	207.273 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CC(CC1=CC2=C(C=C1)OC(O2)(C)C)N;
	InChI InChI=1S/C12H17NO2/c1-8(13)6-9-4-5-10-11(7-9)15-12(2,3)14-10/h4-5,7-8H,6,13H2,1-3H3; Key:HJMCSQZYQOFDAL-UHFFFAOYSA-N;

3,4-Isopropylidenedioxyamphetamine (IDA) is a monoamine releasing agent (MRA) of the amphetamine family related to 3,4-methylenedioxyamphetamine (MDA) developed by David E. Nichols and colleagues.^[1]^[2]^[3] It is considerably less potent than MDA as an MRA in vitro.^[3]^[1] IDA fully substituted for MDMA and LSD in animal drug discrimination tests, albeit with 5- to 7-fold lower potency than MDA.^[3]^[1]